Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate
Latest Information Update: 07 Feb 2023
At a glance
- Drugs Carvedilol (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 18 Feb 2021 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 18 Feb 2021 Status changed from recruiting to active, no longer recruiting.
- 21 Jan 2020 Planned End Date changed from 1 Dec 2019 to 31 Dec 2020.